Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Cancers|September 13, 2025
Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous CarcinomaYali Zhai, Eric R Fearon, Kathleen R Cho
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Preclinical testing of PI3K/AKT/mTOR signaling inhibitors in a mouse model of ovarian endometrioid adenocarcinomaRong Wu, Tom C Hu, Alnawaz Rehemtulla, et al.
Gastroenterology|October 31, 2002
CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasiaTakao Hinoi, Peter C Lucas, Rork Kuick, et al.
Cancer Research|February 3, 2006
Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomasNeali D Hendrix, Rong Wu, Rork Kuick, et al.
The American Journal of Pathology|June 29, 2010
Loss of estrogen receptor 1 enhances cervical cancer invasionYali Zhai, Guido T Bommer, Ying Feng, et al.
Cancer Research|April 17, 2021
Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous CarcinomaLixing Chen, Yali Zhai, Yisheng Wang, et al.
The American Journal of Pathology|March 19, 2013
Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancerRong Wu, Suzanne J Baker, Tom C Hu, et al.
The American Journal of Pathology|June 18, 2013
Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivationYing Feng, Kazuhiro Sentani, Alexandra Wiese, et al.
The Journal of Pathology|June 14, 2017
High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human diseaseYali Zhai, Rong Wu, Rork Kuick, et al.
The Journal of Biological Chemistry|April 10, 2002
Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signalingJanet Y Leung, Frank T Kolligs, Rong Wu, et al.
Pageof 17